Efficacy and Safety Study in Subjects Using Levemir (Insulin Detemir), NovoMix 30 (Biphasic Insulin Aspart 30) [insulin aspart/insulin protamine aspart] and/or NovoRapid (Insulin Aspart) for the Treatment of Type 1 or Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 30 Oct 2016
At a glance
- Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin detemir
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 12 Jul 2012 Additional locations added as reported by ClinicalTrials.gov.
- 23 Oct 2009 Actual initiation date changed from Mar 2008 to Feb 2008 as reported by ClinicalTrials.gov.